Author:
Tsibul’nikov S. Yu.,Maslov L. N.,Tsepokina A. V.,Khutornaya M. V.,Kutikhin A. G.,Tsibul’nikova M. R.,Nam I. F.
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. E. V. Shlyakhto, E. M. Nifontov, and M. M. Galagudza, “Pre- and postconditioning as means of cardioprotection: pathophysiological and clinical aspects,” Zh. Serdech. Nedostat., 9, No. 1, 4–10 (2008).
2. S. Armstrong and C. E. Ganote, “Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischemia,” Cardiovasc. Res., 28, No. 11, 1700–1706 (1994).
3. K. S. Atwal and G. J. Grover, “Treatment of myocardial ischemia with ATP-sensitive potassium channel (KATP) openers,” Curr. Pharmac. Des., 2, 585–595, No. 1996.
4. M. Avkiran and H. Yokoyama, “Adenosine A1 receptor stimulation inhibits α1-adrenergic activation of the cardiac sarcolemmal Na+/H+ exchanger,” Br. J. Pharmacol., 131, No. 4, 659–662 (2000).
5. C. P. Baines, M. V. Cohen, and J. M. Downey, “Signal transduction in ischemic preconditioning: the role of kinases and mitochondrial KATP channels,” J. Cardiovasc. Electrophysiol., 10, No. 5, 741–754 (1999).